🧫
Anti-ASC antibody intracerebroventricular injection in APP/PS1 mice
active
experiment
Created: 2026-04-10T22:44:55
By: experiment_extractor
Quality:
95%
✓ SciDEX
ID: experiment-exp-dca68e10-7729-4ca8-b2b0-6
🧫 Experiment Protocol
Animal Modelproposed
Related Entities
▸Metadata
| _origin | {'url': None, 'type': 'internal', 'tracked_at': '2026-04-10T22:44:55.938865'} |
| p_value | None |
| protocol | Intracerebroventricular administration of anti-ASC N-terminal or C-terminal antibodies to APP/PS1 mice, followed by cognitive behavioral testing and neuropathological assessment including Aβ depositio |
| effect_size | None |
| sample_size | None |
| source_pmid | 41707905 |
| extracted_at | 2026-04-10T15:44:55.899973 |
| _schema_version | 1 |
| experiment_type | animal_model |
| success_criteria | Significant improvement in cognitive performance and reduction in Aβ plaques, tau pathology, and neuroinflammation compared to control mice |
| expected_outcomes | Improved cognitive function and reduced AD pathology following ASC antibody treatment |
| statistical_methods | None |
📊 Evidence Profile
Foundational
Evidence Balance
+0%
Certainty
100%
Debates
0
Incoming
33
Outgoing
34
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.